The strong correlation between kio and Ki67+ in the dynamic changes and spatial variations of proliferation activity, along with its predictive power in machine learning models, positions kio as a promising MRI biomarker for the non-invasive spatiotemporal assessment of glioma proliferation. The gene discussed is MKI67; the disease is central nervous system cancer.